$CLRO
CLEARONE INC Stock $clro

$clro Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000175392623000676 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$5.483M	$4.178M	$4.021M
YoY Change	-25.65%	-44.63%	-44.17%
Cost Of Revenue	$3.635M	$2.863M	$2.757M
YoY Change	-20.42%	-39.46%	-39.59%
Gross Profit	$1.848M	$1.315M	$1.264M
YoY Change	-34.16%	-53.3%	-52.08%
Gross Profit Margin	33.7%	31.47%	31.43%
Selling, General & Admin	$2.330M	$2.461M	$2.870M
YoY Change	-28.94%	-25.78%	-19.68%
% of Gross Profit	126.08%	187.15%	227.06%
Research & Development	$873.0K	$1.043M	$984.0K
YoY Change	-25.83%	-22.91%	-36.15%
% of Gross Profit	47.24%	79.32%	77.85%
Depreciation & Amortization	$228.0K	$221.0K	$580.0K
YoY Change	-71.46%	-72.17%	-29.7%
% of Gross Profit	12.34%	16.81%	45.89%
Operating Expenses	$3.203M	$3.504M	$3.854M
YoY Change	-28.12%	-24.95%	-24.64%
Operating Profit	-$1.355M	-$2.189M	-$2.590M
YoY Change	-17.83%	18.13%	4.6%
Interest Expense	-$91.00K	$292.0K	-$135.0K
YoY Change	-196.81%	189.11%	-6.9%
% of Operating Profit
Other Income/Expense, Net	$437.0K	$1.666M	$33.60M
YoY Change	-70.96%	55433.33%	223880.0%
Pretax Income	-$1.009M	-$815.0K	$30.87M
YoY Change	323.95%	-58.23%	-1284.65%
Income Tax	$10.00K	$17.00K	$6.844M
% Of Pretax Income			22.17%
Net Earnings	-$1.019M	-$832.0K	$24.03M
YoY Change	296.5%	-57.7%	-1152.01%
Net Earnings / Revenue	-18.58%	-19.91%	597.56%
Basic Earnings Per Share	-$0.04	-$0.03
Diluted Earnings Per Share	-$0.04	-$0.03	$0.83
COMMON SHARES
Basic Shares Outstanding	23.96M shares	23.96M shares	23.95M shares
Diluted Shares Outstanding	23.96M shares	23.96M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.49M	$59.01M	$984.0K
YoY Change	1686.7%	2398.14%	-75.89%
Cash & Equivalents	$15.09M	$59.01M	$984.0K
Short-Term Investments	$6.408M		$0.00
Other Short-Term Assets	$4.273M	$3.635M	$7.808M
YoY Change	46.14%	7.86%	94.18%
Inventory	$7.547M	$8.395M	$8.961M
Prepaid Expenses
Receivables	$4.232M	$3.541M	$3.603M
Other Receivables	$6.381M	$0.00	$56.07M
Total Short-Term Assets	$43.93M	$74.58M	$77.43M
YoY Change	71.38%	169.5%	162.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.785M	$356.0K	$383.0K
YoY Change	190.72%	-47.34%	-48.52%
Goodwill
YoY Change
Intangibles	$1.903M	$1.995M	$2.071M
YoY Change	-92.17%	-91.91%	-91.74%
Long-Term Investments	$586.0K		$0.00
YoY Change			-100.0%
Other Assets	$3.475M	$112.0K	$115.0K
YoY Change	-24.32%	-97.56%	-97.5%
Total Long-Term Assets	$7.749M	$6.607M	$6.323M
YoY Change	-77.02%	-81.17%	-82.8%
TOTAL ASSETS
Total Short-Term Assets	$43.93M	$74.58M	$77.43M
Total Long-Term Assets	$7.749M	$6.607M	$6.323M
Total Assets	$51.68M	$81.18M	$83.75M
YoY Change	-12.93%	29.37%	26.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.435M	$1.820M	$1.284M
YoY Change	18.95%	-55.88%	-76.17%
Accrued Expenses	$2.587M	$2.454M	$3.041M
YoY Change	0.66%	-13.16%	19.3%
Deferred Revenue	$52.00K	$71.00K	$63.00K
YoY Change	20.93%	54.35%	16.67%
Short-Term Debt	$1.380M	$1.556M	$3.732M
YoY Change	70.37%	16.47%	7.21%
Long-Term Debt Due	$1.380M	$1.556M	$1.920M
YoY Change	70.37%	103.4%	166.67%
Total Short-Term Liabilities	$6.454M	$5.901M	$8.120M
YoY Change	17.99%	-29.19%	-29.22%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Long-Term Liabilities	$1.856M	$1.008M	$1.008M
YoY Change	183.36%	-33.94%	53.89%
Total Long-Term Liabilities	$1.856M	$1.008M	$1.008M
YoY Change	0.92%	-25.83%	-53.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.454M	$5.901M	$8.120M
Total Long-Term Liabilities	$1.856M	$1.008M	$1.008M
Total Liabilities	$8.310M	$7.858M	$9.620M
YoY Change	3.54%	-29.95%	-34.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.367M	-$1.348M	-$516.0K
YoY Change	-89.84%	-94.15%	-97.55%
Common Stock	$46.00M	$74.96M	$74.93M
YoY Change	-38.57%	0.14%	2.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$43.37M	$73.33M	$74.13M
YoY Change
Total Liabilities & Shareholders Equity	$51.68M	$81.18M	$83.75M
YoY Change	-12.93%	29.37%	26.53%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	-$1.019M	-$832.0K	$24.03M
YoY Change	296.5%	-57.7%	-1152.01%
Depreciation, Depletion And Amortization	$228.0K	$221.0K	$580.0K
YoY Change	-71.46%	-72.17%	-29.7%
Cash From Operating Activities	-$7.401M	$60.32M	-$2.119M
YoY Change	348.82%	-5883.41%	-27.36%
INVESTING ACTIVITIES
Capital Expenditures	$336.0K	$27.00K	$78.00K
YoY Change	8300.0%	237.5%	-130.95%
Acquisitions
YoY Change
Other Investing Activities	-$6.988M	$0.00	-$93.00K
YoY Change	-1162.01%	-100.0%	-97.73%
Cash From Investing Activities	-$7.324M	-$69.00K	-$171.0K
YoY Change	-1206.34%	-103.89%	-96.06%
FINANCING ACTIVITIES
Cash Dividend Paid	$28.98M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-29.20M	-$2.225M	1.820M
YoY Change	-3853.6%	504.62%	-320.61%
NET CHANGE
Cash From Operating Activities	-7.401M	$60.32M	-2.119M
Cash From Investing Activities	-7.324M	-$69.00K	-171.0K
Cash From Financing Activities	-29.20M	-$2.225M	1.820M
Net Change In Cash	-43.93M	$58.03M	-470.0K
YoY Change	20918.18%	15842.58%	-94.19%
FREE CASH FLOW
Cash From Operating Activities	-$7.401M	$60.32M	-$2.119M
Capital Expenditures	$336.0K	$27.00K	$78.00K
Free Cash Flow	-$7.737M	$60.29M	-$2.197M
YoY Change	368.06%	-5836.82%	-17.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Inventory Net InventoryNet	8961000	usd
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-368000	usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000840715
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CLEARONE INC
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23955767	shares
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	326000	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-33660
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0398877
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5225 Wiley Post Way, Suite 500
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84116
CY2023Q1	dei	City Area Code CityAreaCode	(801)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	975-7200
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001
CY2023Q1	dei	Trading Symbol TradingSymbol	CLRO
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23955767	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59006000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	984000	usd
CY2023Q1	clro	Receivables Legal Settlement ReceivablesLegalSettlement	0	usd
CY2022Q4	clro	Receivables Legal Settlement ReceivablesLegalSettlement	55000000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	326000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	326000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3541000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3603000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	8395000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8961000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1071000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7808000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	74577000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	77427000	usd
CY2023Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	2885000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2707000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	356000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	383000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1259000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1047000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1995000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	112000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	115000	usd
CY2023Q1	us-gaap	Assets Assets	81184000	usd
CY2022Q4	us-gaap	Assets Assets	83750000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1820000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1284000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2454000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3041000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	71000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	63000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1556000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	3732000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5901000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8120000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	949000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	492000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1008000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1008000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	7858000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	9620000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23955767	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23955767	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23955767	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74933000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74910000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-283000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-288000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1348000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-516000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	73326000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	74130000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81184000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83750000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7545000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2863000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4729000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1315000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	2816000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1192000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1560000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1043000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1353000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1269000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1756000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3504000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4669000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2189000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1853000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	292000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	101000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1666000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-815000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1951000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-832000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23955767	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23897305	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23955767	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23897305	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-832000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-28000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	5000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-11000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-827000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2006000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-832000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	221000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	794000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	129000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	154000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	23000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	36000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	23000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	8000	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-62000	usd
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	86000	usd
CY2023Q1	clro	Increase Decrease In Legal Settlement Receivables IncreaseDecreaseInLegalSettlementReceivables	-55000000	usd
CY2022Q1	clro	Increase Decrease In Legal Settlement Receivables IncreaseDecreaseInLegalSettlementReceivables	0	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-365000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-525000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4176000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-651000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	536000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1263000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-551000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	286000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	1293000	usd
CY2022Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-5000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	8000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-8000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-124000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-160000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	60321000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1043000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	42000	usd
CY2023Q1	clro	Capitalized Patent Defense Costs CapitalizedPatentDefenseCosts	0	usd
CY2022Q1	clro	Capitalized Patent Defense Costs CapitalizedPatentDefenseCosts	189000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2042000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-69000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1775000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	2225000	usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	370000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2225000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-13000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	58031000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	351000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	986000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59017000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1422000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	18000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	26000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	231000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	51000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59006000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	984000	usd
CY2023Q1	clro	Working Capital Deficit WorkingCapitalDeficit	68676000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	60321000	usd
CY2023Q1	clro	Increase Decrease In Net Cash Provided By Used In Operating Activities IncreaseDecreaseInNetCashProvidedByUsedInOperatingActivities	61364000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1043000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4178000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7545000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7545000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23955767	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23897305	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23955767	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q1	clro	Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding	6368420	shares
CY2022Q1	clro	Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding	7062673	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6368420	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7062673	shares
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10953000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10912000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8958000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8841000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1995000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2071000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	118000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	670000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	398000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	253000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	192000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	191000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	61000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	900000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1995000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4552000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4499000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3843000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4462000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	8395000	usd
CY2023Q1	clro	Inventory Noncurrent Raw Materials Net Of Reserves InventoryNoncurrentRawMaterialsNetOfReserves	928000	usd
CY2022Q4	clro	Inventory Noncurrent Raw Materials Net Of Reserves InventoryNoncurrentRawMaterialsNetOfReserves	1068000	usd
CY2023Q1	clro	Inventory Noncurrent Finished Goods Net Of Reserves InventoryNoncurrentFinishedGoodsNetOfReserves	1957000	usd
CY2022Q4	clro	Inventory Noncurrent Finished Goods Net Of Reserves InventoryNoncurrentFinishedGoodsNetOfReserves	1639000	usd
CY2023Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	2885000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2707000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	23000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	149000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	179000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	151000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	183000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	758000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1259000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1047000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	382000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	641000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	949000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	492000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1331000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1133000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M13D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0637	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0593	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	341000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	439000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	272000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	210000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	216000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	37000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1515000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	184000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1331000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	73326000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	51536000	usd
CY2023Q1	clro	Warrants Carrying Amount WarrantsCarryingAmount	318000	usd
CY2022Q4	clro	Warrants Carrying Amount WarrantsCarryingAmount	318000	usd
CY2023Q1	clro	Warrant Instrument Convertible Beneficial Conversion Feature WarrantInstrumentConvertibleBeneficialConversionFeature	122000	usd
CY2022Q4	clro	Warrant Instrument Convertible Beneficial Conversion Feature WarrantInstrumentConvertibleBeneficialConversionFeature	122000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	440000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1695000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1695000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	962000	usd

Files In Submission

Name	View Source	Status
0001753926-23-000676-index-headers.html	Edgar Link	pending
0001753926-23-000676-index.html	Edgar Link	pending
0001753926-23-000676.txt	Edgar Link	pending
0001753926-23-000676-xbrl.zip	Edgar Link	pending
clro-20230331.htm	Edgar Link	pending
clro-20230331.xsd	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
clro-20230331_def.xml	Edgar Link	unprocessable
clro-20230331_lab.xml	Edgar Link	unprocessable
clro-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
clro-20230331_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
clro-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRO
CLEARONE INC Stock $clro

2023 Q2 Form 10-Q Financial Statement

#000175392623000676 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRO CLEARONE INC Stock $clro

2023 Q2 Form 10-Q Financial Statement

#000175392623000676 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRO
CLEARONE INC Stock $clro